Foren & Soziale Netzwerke zur VERTEX PHARMACEUTICALS Aktie

 

? Chart Analysis Summary: Pattern: A symmetrical triangle is visible, tightening toward the apex with a breakout just forming. Current Price: $472.47 (breakout near) Key Levels: Support Zone: Around $468–470 (white/yellow zone) Resistance Zone: First Target: $477.01 (red line) Major Target: $482.20 (green line) Volume Confirmation: Suggested to confirm breakout with volume increase. ? Trade Idea (Long Setup): Entry: $472.50–473.00 Target 1: $477.00 Target 2: $482.00 Stop-Loss: Below $468.00

Kursziel: 442.3452 €

Kursziel: -

Kursziel: -

Kursziel: 455.981 €

Kursziel: 465.45 €

Kursziel: 480.0 €

Kursziel: -

Kursziel: 523.0008 €

Kursziel: 485.0 €

Vertex Pharmaceuticals ended January with a big rally. Now, after a pullback, some traders may see an opportunity. The first pattern on today's chat is the price gap on January 31 after the FDA approved its Journavx painkiller. (It's the first of its kind to treat pain a unique way without addition risks.) The stock has retraced the surge, which may appeal to dip buyers. Second is the October 7 close of $448.60. VRTX held that level in late November and again on December 18 before gapping down. The stock is now trying to stabilize in the same location, suggesting support may remain in effect. Next, the MACD surge in January could reflect bullish short-term momentum. Prices are also trying to hold the rising 21-day exponential moving average. Finally, VRTX is near its 50-, 100- and 200-day simple moving averages. That may create potential for the longer-term trend to accelerate if the short-term strength continues. TradeStation has, for decades, advanced the trading industry, providing access to stocks,

Kursziel: 502.372 €

Kursziel: 464.4 €

Kursziel: 532.62 €

Kursziel: -

Kursziel: 525.0 €

Kursziel: -

Kursziel: 461.568 €

Kursziel: 507.3627 €

Kursziel: 456.576 €